HAVN Life Sciences Inc. is a listed company. Its insiders report their share dealings to SEDI. No insider at HAVN Life Sciences Inc. has published a filing in the past twelve months. The most recent one dates from 24 March 2022.
The full history, which starts in 2020, counts no purchases against 6 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
18 of 18 declarations
HAVN Life Sciences Inc. is a company focused on developing psychedelic-based products for mental wellness. It is listed on the Toronto Stock Exchange under the symbol XTSE.